Langseth H - Search Results

1

microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples.

Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE. Rounge TB, et al. Among authors: langseth h. Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1381-7. doi: 10.1158/1055-9965.EPI-15-0289. Epub 2015 Jun 24. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26108462

2

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A. Bjørge T, et al. Among authors: langseth h. Br J Cancer. 2004 Nov 15;91(10):1829-34. doi: 10.1038/sj.bjc.6602199. Br J Cancer. 2004. PMID: 15477862 Free PMC article.

3

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.

Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Keller A, et al. Among authors: langseth h. RNA Biol. 2011 May-Jun;8(3):506-16. doi: 10.4161/rna.8.3.14994. Epub 2011 May 1. RNA Biol. 2011. PMID: 21558792

4

Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.

Andersson K, Luostarinen T, Strand AS, Langseth H, Gislefoss RE, Forslund O, Pawlita M, Waterboer T, Dillner J. Andersson K, et al. Among authors: langseth h. Int J Cancer. 2013 Oct 15;133(8):1840-5. doi: 10.1002/ijc.28188. Epub 2013 Apr 25. Int J Cancer. 2013. PMID: 23553409 Free article.

5

Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.

Wibom C, Späth F, Dahlin AM, Langseth H, Hovig E, Rajaraman P, Johannesen TB, Andersson U, Melin B. Wibom C, et al. Among authors: langseth h. Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):810-6. doi: 10.1158/1055-9965.EPI-14-1106. Epub 2015 Feb 20. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25713050

6

HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank.

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L. Gislefoss RE, et al. Among authors: langseth h. Int J Gynecol Cancer. 2015 Nov;25(9):1608-15. doi: 10.1097/IGC.0000000000000532. Int J Gynecol Cancer. 2015. PMID: 26501436

7

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J. Lumme S, et al. Among authors: langseth h. Acta Oncol. 2016 Jul;55(7):839-45. doi: 10.3109/0284186X.2016.1139178. Epub 2016 Feb 15. Acta Oncol. 2016. PMID: 26878091

8

Cohort Profile: The Janus Serum Bank Cohort in Norway.

Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G. Langseth H, et al. Int J Epidemiol. 2017 Apr 1;46(2):403-404g. doi: 10.1093/ije/dyw027. Int J Epidemiol. 2017. PMID: 27063606 No abstract available.

9

Effect of multiple freeze-thaw cycles on selected biochemical serum components.

Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L. Gislefoss RE, et al. Among authors: langseth h. Clin Chem Lab Med. 2017 Jun 27;55(7):967-973. doi: 10.1515/cclm-2016-0892. Clin Chem Lab Med. 2017. PMID: 27987362

10

Cohort Profile Update: The Janus Serum Bank Cohort in Norway.

Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth H. Hjerkind KV, et al. Among authors: langseth h. Int J Epidemiol. 2017 Aug 1;46(4):1101-1102f. doi: 10.1093/ije/dyw302. Int J Epidemiol. 2017. PMID: 28087783 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page